INTAL Drug Patent Profile
✉ Email this page to a colleague
When do Intal patents expire, and what generic alternatives are available?
Intal is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in three NDAs.
The generic ingredient in INTAL is cromolyn sodium. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Intal
A generic version of INTAL was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INTAL?
- What are the global sales for INTAL?
- What is Average Wholesale Price for INTAL?
Summary for INTAL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Patent Applications: | 3,608 |
DailyMed Link: | INTAL at DailyMed |
US Patents and Regulatory Information for INTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms Llc | INTAL | cromolyn sodium | AEROSOL, METERED;INHALATION | 018887-001 | Dec 5, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INTAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | INTAL | cromolyn sodium | AEROSOL, METERED;INHALATION | 018887-001 | Dec 5, 1985 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | INTAL | cromolyn sodium | AEROSOL, METERED;INHALATION | 018887-001 | Dec 5, 1985 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | ⤷ Sign Up | ⤷ Sign Up |
King Pharms Llc | INTAL | cromolyn sodium | SOLUTION;INHALATION | 018596-001 | May 28, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | INTAL | cromolyn sodium | CAPSULE;INHALATION | 016990-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for INTAL
See the table below for patents covering INTAL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Malaysia | 8300014 | A NOVEL FORM OF DISODIUM | ⤷ Sign Up |
Norway | 780183 | ⤷ Sign Up | |
Italy | 7825845 | ⤷ Sign Up | |
Japan | S5643448 | ⤷ Sign Up | |
Netherlands | 6811060 | ⤷ Sign Up | |
Germany | 1918142 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |